INTRODUCTION
The synthesis of glucose from non-carbohydrate precursors occurs mainly in the liver and kidney. Understanding how glucose metabolism is finely regulated in the liver at molecular and cellular levels is critical for knowing its relationship to related pathologies, such as diabetes.
OBJECTIVES
In order to gain insight the regulation of glucose metabolism, we studied the liver expressed isoforms aldolase-B and fructose-1,6-bisphosphatase (FBPase-1), key enzymes in gluconeogenesis, analyzing their cellular localization in hepatocytes under different metabolic conditions and their protein-protein interaction in vitro and in vivo.
MATERIALS AND METHODS
The localization of aldolase-B and FBPase-1 in cultured rat hepatocytes was studied using immunofluorescence and confocal microscopy. The in vitro and in vivo interaction between these proteins was studied using protein-protein overlay assay, GST pull down, equilibrium chromatography, SPR and FRET.
DISCUSSION AND RESULTS
We observed that glucose, insulin, glucagon and adrenaline differentially modulate the intracellular distribution of aldolase-B and FBPase-1. Interestingly, the in vitro protein-protein interaction analysis between aldolase-B and FBPase-1 showed a specific and regulatable interaction between them, whereas aldolase-A (muscle isozyme) and FBPase-1 showed no interaction. The affinity of the aldolase-B and FBPase-1 complex was modulated by intermediate metabolites, but only in the presence of K + . We observed a decreased association constant in the presence of AMP, fructose-2,6-bisphosphate, fructose-6-phosphate and inhibitory concentrations of fructose-1,6-bisphosphate. Conversely, the association constant of the complex increased in the presence of dihydroxyacetone phosphate and non-inhibitory concentrations of fructose-1,6-bisphosphate. Notably, in vivo FRET studies confirmed the interaction between aldolase-B and FBPase-1. Also, the co-expression of aldolase-B and FBPase-1 in cultured cells suggested that FBPase-1 guides the cellular localization of aldolase-B.
CONCLUSIONS
Our results provide further evidence that metabolic conditions modulate aldolase B and FBPase-1 activity at the cellular level via the regulation of their interaction, suggesting that their association confers a catalytic advantage for both enzymes. (Grant: FONDECYT 1141033).
